U.S. Spatial Genomics & Transcriptomics Market (2024 - 2030) Size, Share & Trends Analysis Report By Technology (Spatial Transcriptomics, Spatial Genomics), By Product (Consumables, Software), By End-use, And Segment Forecasts

Market Segmentation

U.S. Spatial Genomics & Transcriptomics Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Instruments
  - By Mode
    - Automated
    - Semi-automated
    - Manual
  - By Type
    - Sequencing Platforms
    - IHC
    - Microscopy
    - Flow Cytometry
    - Mass Spectrometry
    - Others
- Consumables
- Software
  - Bioinformatics Tools
  - Imaging Tools
  - Storage and Management Databases
U.S. Spatial Genomics & Transcriptomics Product Outlook (Revenue, USD Million, 2018 - 2030)
- Spatial Transcriptomics
  - Sequencing-Based Methods
    - Laser Capture Microdissection (LCM)
      - FFPE Tissue Samples
      - Others
    - Transcriptome In-Vivo Analysis (TIVA)
    - In Situ Sequencing
    - Microtomy Sequencing
  - IHC
  - Microscopy-based RNA Imaging Techniques
    - Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)
    - Padlock Probes/ Rolling Circle Amplification
    - Branched DNA Probes
- Spatial Genomics
  - FISH
  - Microscopy-based Live DNA Imaging
  - Genome Perturbation Tools
  - Massively-Parallel Sequencing
  - Biochemical Techniques
  - Others
U.S. Spatial Genomics & Transcriptomics End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Translational Research
- Academic Customers
- Diagnostic Customers
- Pharmaceutical Manufacturer

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments